💡 Bottom Line Up Front
The most important blood type issue in pregnancy is Rh incompatibility: if you're Rh-negative (e.g., O-, A-, B-) and your baby is Rh-positive (inherited from the father), your immune system can develop antibodies that attack future Rh-positive pregnancies. This is completely preventable with an injection called RhoGAM. ABO incompatibility (e.g., type O mother, type A baby) is common but almost always mild. Blood type testing is routine in prenatal care.
Rh Factor: The One That Matters
About 15% of people are Rh-negative. If you're Rh-negative and your partner is Rh-positive, your baby may be Rh-positive. The concern:
- During birth (or miscarriage, ectopic pregnancy, or invasive procedures), fetal blood can mix with maternal blood
- The Rh-negative mother's immune system recognizes Rh-positive blood cells as foreign and creates antibodies against them
- In a subsequent Rh-positive pregnancy, these antibodies can cross the placenta and attack the baby's red blood cells, causing hemolytic disease of the newborn (HDN)
The solution: RhoGAM (Rh immune globulin) is given at 28 weeks of pregnancy and within 72 hours of delivery (or any bleeding event). It prevents the mother's immune system from producing Rh antibodies. This prophylaxis has reduced HDN from a leading cause of neonatal death to an extremely rare event.
⚠ Get tested early
Blood type and Rh factor testing is standard at your first prenatal visit. If you're Rh-negative, you'll receive RhoGAM automatically at 28 weeks and after delivery. If you've had a miscarriage, ectopic pregnancy, or any vaginal bleeding, tell your doctor — you may need an earlier dose. If Rh antibodies have already formed (from a prior unsensitized pregnancy), RhoGAM cannot help, but the pregnancy will be monitored closely with additional ultrasounds and possibly blood transfusions for the baby.
ABO Incompatibility
ABO incompatibility (e.g., type O mother with type A or B baby) is actually more common than Rh incompatibility. However, it's almost always mild:
- Anti-A and anti-B antibodies are large IgM molecules that don't cross the placenta efficiently
- When it does cause problems, it's typically mild newborn jaundice that resolves with phototherapy
- No prophylaxis is needed (unlike Rh)
- It can occur in the first pregnancy (unlike Rh, which typically requires prior sensitization)
| Blood Type Combination | Risk Level | Action Needed |
|---|---|---|
| Both partners same Rh (+ or -) | No Rh risk | Standard prenatal care |
| Mother Rh+, father Rh- | No risk | Baby will be Rh+ or Rh- but mom is already positive |
| Mother Rh-, father Rh+ | Rh risk | RhoGAM at 28 weeks + after delivery; antibody screening at first visit |
| Mother type O, father type A or B | Mild ABO risk | Monitor for newborn jaundice; usually self-resolving |
| All other ABO combinations | Minimal risk | Standard prenatal care |
Planning Ahead?
FertileStart covers everything you need to know before you start trying.
Visit FertileStartKeep Reading
More from our fertility network
Priced Out of US Fertility Treatment?
IVF in the US averages $20,000–$25,000 per cycle. Internationally accredited clinics abroad offer the same care for 50–70% less — with success rates that match or exceed US averages.
Explore Affordable IVF Abroad →This link connects you with international fertility treatment resources. We may receive referral compensation at no cost to you.